Alprazolam
Product Images NDC 53002-3950

3 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Alprazolam (NDC 53002-3950). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fragments (Fr2)

Fragments (Fr2)
An illustration showing the segmentation of an Alprazolam 2 mg tablet from RPK Pharmaceuticals, Inc. The image depicts the complete tablet, its division into two 1 mg segments, and further subdivision into four 0.5 mg segments, indicating the tablet's scored design for dose splitting.*
FDA Label Image

Label Image (Lbl530023950)

Label Image (Lbl530023950)
Alprazolam 0.5 mg tablets label by RPK Pharmaceuticals, Inc. The label shows prescription use with 20 tablets per bottle and instructions to take a specified number of tablets by the prescriber. It displays the product NDC 53002-3950 and space for clinic name and lot details.*
FDA Label Image

Structure (Str2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.